关注
Saad Sirop Kenderian
Saad Sirop Kenderian
Hematology and BMT, Mayo Clinic
在 mayo.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Human chimeric antigen receptor macrophages for cancer immunotherapy
M Klichinsky, M Ruella, O Shestova, XM Lu, A Best, M Zeeman, ...
Nature biotechnology 38 (8), 947-953, 2020
9222020
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
M Ruella, DM Barrett, SS Kenderian, O Shestova, TJ Hofmann, ...
The Journal of clinical investigation 126 (10), 3814-3826, 2016
5912016
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
RM Sterner, R Sakemura, MJ Cox, N Yang, RH Khadka, CL Forsman, ...
Blood, The Journal of the American Society of Hematology 133 (7), 697-709, 2019
5322019
CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia
SS Kenderian, M Ruella, O Shestova, M Klichinsky, V Aikawa, ...
Leukemia 29 (8), 1637-1647, 2015
4532015
Genetic inactivation of CD33 in hematopoietic stem cells to enable CAR T cell immunotherapy for acute myeloid leukemia
MY Kim, KR Yu, SS Kenderian, M Ruella, S Chen, TH Shin, AA Aljanahi, ...
Cell 173 (6), 1439-1453. e19, 2018
4102018
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow …
AJ Kansagra, NV Frey, M Bar, TW Laetsch, PA Carpenter, BN Savani, ...
Bone marrow transplantation 54 (11), 1868-1880, 2019
206*2019
Neurotoxicity and cytokine release syndrome after chimeric antigen receptor T cell therapy: insights into mechanisms and novel therapies
EL Siegler, SS Kenderian
Frontiers in immunology 11, 1973, 2020
2002020
The Addition of the BTK inhibitor Ibrutinib to anti-CD19 chimeric antigen receptor T cells (CART19) improves responses against mantle cell lymphoma
M Ruella, SS Kenderian, O Shestova, JA Fraietta, S Qayyum, Q Zhang, ...
Clinical Cancer Research 22 (11), 2684-2696, 2016
1962016
Overcoming the immunosuppressive tumor microenvironment of Hodgkin lymphoma using chimeric antigen receptor T cells
M Ruella, M Klichinsky, SS Kenderian, O Shestova, A Ziober, DO Kraft, ...
Cancer discovery 7 (10), 1154-1167, 2017
1732017
Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemia
SK Tasian, SS Kenderian, F Shen, M Ruella, O Shestova, M Kozlowski, ...
Blood, The Journal of the American Society of Hematology 129 (17), 2395-2407, 2017
1702017
Next-generation chimeric antigen receptor T-cell therapy: going off the shelf
M Ruella, SS Kenderian
BioDrugs 31 (6), 473-481, 2017
1422017
Treatment of cancer using anti-CD19 Chimeric Antigen Receptor
CH June, DL Porter, M Maus, M Wasik, S Gill, J Fraietta, M Ruella, J Byrd, ...
US Patent 10,357,514, 2019
1332019
Anti-CD19 chimeric antigen receptor T-cell therapy in acute lymphocytic leukaemia: a systematic review and meta-analysis
T Anagnostou, IB Riaz, SK Hashmi, MH Murad, SS Kenderian
The Lancet Haematology 7 (11), e816-e826, 2020
1172020
Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms
M Ruella, SS Kenderian, O Shestova, M Klichinsky, JJ Melenhorst, ...
Leukemia 31 (1), 246-248, 2017
1132017
CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities
LAK Fonkoua, O Sirpilla, R Sakemura, EL Siegler, SS Kenderian
Molecular Therapy-Oncolytics 25, 69-77, 2022
1072022
GM-CSF neutralization with lenzilumab in severe COVID-19 pneumonia: a case-cohort study
Z Temesgen, M Assi, FNU Shweta, P Vergidis, SA Rizza, PR Bauer, ...
Mayo Clinic Proceedings 95 (11), 2382-2394, 2020
1062020
Treatment of cancer using a CD123 chimeric antigen receptor
J Brogdon, S Gill, D Glass, S Kenderian, A Loew, J Mannick, MC Milone, ...
US Patent 9,815,901, 2017
1042017
Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center
Y Wang, MA Tschautscher, KG Rabe, TG Call, JF Leis, SS Kenderian, ...
Haematologica 105 (3), 765, 2020
972020
Chimeric antigen receptor T cells and hematopoietic cell transplantation: how not to put the CART before the horse
SS Kenderian, DL Porter, S Gill
Biology of Blood and Marrow Transplantation 23 (2), 235-246, 2017
922017
Treatment of cancer using a CLL-1 chimeric antigen receptor
J Brogdon, HE Ebersbach, S Gill, D Glass, J Jascur, S Kenderian, ...
US Patent 10,568,947, 2020
892020
系统目前无法执行此操作,请稍后再试。
文章 1–20